Filters

Imipenem monohydrate manufacturers

Filters

imipenem monohydrate + cilastatin

Injection 500 mg+500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19464
This company is a leading generic pharmaceutical manufacturer with over six decades of experience. They produce a wide range of products, including prescription medications, over-the-counter drugs, injectables, liquids, and external preparations. Their therapeutic areas include antibiotics, anti-diabetics, anti-malarials, NSAIDs, cardiology medications, central nervous system drugs, gastrointestinal agents, hormones, respiratory/anti-allergic medications, urology/infertility treatments, and health supplements. The company holds various certifications including ISO 9001, ISO 15378, GMP, WHO-GMP, and FSSAI. They export their products to over 30 countries across the globe, with a significant portion of their turnover coming from international operations. They emphasize quality assurance through rigorous testing and analysis at various stages of product development and manufacturing.

Manufacturer usually replies in 11 days

imipenem monohydrate + cilastatin

Powder for solution for infusion 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
PICS
Manufacturer #540
This global pharmaceutical company boasts an impressive 80 years of experience in developing and delivering a diverse range of products. Their portfolio spans prescription medications, over-the-counter drugs, herbal teas, and penicillin production. They hold over 1643 marketing authorizations for more than 400 products distributed across 50 countries. Key therapy areas include those addressing respiratory health, pain management, and cardiovascular conditions. Their manufacturing facilities are equipped to produce various dosage forms including effervescent & oral liquids, topical preparations, softgels, and oral solids. The company prioritizes quality with GMP certifications, reflecting their commitment to safety and efficacy.

Manufacturer usually replies in 34 days

imipenem monohydrate + cilastatin sodium

Powder for solution for infusion 500 mg + 500 mg - 25 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430
This pharmaceutical company has over 20 years of experience serving domestic and international markets in diverse regions like the EU and North America. They specialize in manufacturing a wide range of pharmaceutical products, including prescription medications, likely encompassing key therapy areas such as nephrology, cardiology, oncology, and pediatrics. Their product portfolio includes various dosage forms and boasts GMP certifications. They actively engage in research and development, evidenced by mentions of new drug launches like "Urapidil" for hypertension and "Bivalirudin" used in COVID-19 patients with ECMO. While they do not engage in online sales, the company emphasizes its commitment to quality and high-tech production facilities.

Manufacturer usually replies in 17 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.